Please provide your email address to receive an email when new articles are posted on . Tempus announced the FDA has granted a breakthrough device designation to its ECG analysis platform for the ...

Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap Clearance Expands vMap’s Non-Invasive Mapping ...

The 12-lead ECG remains the gold standard of diagnosing AF. 8 The ECG will be positive for lack of a p-wave, an oscillatory baseline wave with varying amplitudes, irregular rhythm, and the classic ...

Saint-Etienne, France - Radiofrequency ablation is more effective than treatment with amiodarone for the prevention of atrial flutter recurrence in patients who experienced a first symptomatic episode ...

Philadelphia, October 12, 2022 – Extended cardiac monitoring in patients and the use of implantable cardiovascular electronic devices can increase detection of atrial fibrillation (AF), but the ...

With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...